George Larry Geisler Iv, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Lincoln Hwy, Fairless Hills, PA 19030 Phone: 267-587-0775 Fax: 215-710-5861 |
News Archive
Reclast (zoledronic acid) Injection has been approved by the US Food and Drug Administration (FDA) as the first and only therapy to prevent postmenopausal osteoporosis for two years with a single dose. Reclast is already approved as a once-yearly infusion for the treatment of postmenopausal osteoporosis.
The measure, which awaits the president's signature, puts off large cuts in federal spending and increases taxes. But it delays efforts to revamp entitlement programs.
Chimeric antigen receptor T-cell therapy, or CAR T, was named the 2017 Advance of the Year by the American Society of Clinical Oncology. The FDA approved two CAR T products last year for treatment of adult large B-cell lymphoma based on the exceptional patient outcomes seen in clinical trials.
Today's health policy headlines include the feature coverage of aspects of health reform implementation, including how "gradfathering" will be defined in regulations and the latest details on the early retiree reinsurance program.
› Verified 6 days ago